NCT00756366View on ClinicalTrials.gov

CPAP Therapy in Patients With Heart Failure and Obstructive Sleep Apnea.

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2011

Study Completion Date

December 31, 2011

Conditions
Heart FailureObstructive Sleep Apnea
Interventions
OTHER

Positron Emission Tomography

PET imaging at baseline, 1 week and 6-8 weeks. CPAP begins after baseline PET scan.

OTHER

Positron Emission Tomography

PET imaging at Baseline, 1 week and 6-8 weeks. CPAP begins after 6-8 week PET scan.

OTHER

Positron Emission Tomography

PET scan at baseline and 6-8 weeks, no CPAP therapy

Trial Locations (1)

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
collaborator

Heart and Stroke Foundation of Ontario

OTHER

lead

Ottawa Heart Institute Research Corporation

OTHER

NCT00756366 - CPAP Therapy in Patients With Heart Failure and Obstructive Sleep Apnea. | Biotech Hunter | Biotech Hunter